As NCOR2 is a transcriptional co-repressor gene, this finding suggests that BQ overexpression competes with NCOR2 to diminish the repression of ACSL4, leading to its upregulation, outlining the mechanism through which BQ modulates ACSL4 expression in breast cancer. The gene discussed is ACSL4; the disease is breast carcinoma.